PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 29(3): 319-324
2009
© 2009 International Society for Peritoneal Dialysis
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasegawa, T.
Right arrow Articles by Ideura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasegawa, T.
Right arrow Articles by Ideura, T.

Clinical

A STRICT LOW PROTEIN DIET DURING THE PREDIALYSIS PERIOD SUPPRESSES PERITONEAL PERMEABILITY AT INDUCTION OF PERITONEAL DIALYSIS

Takeshi Hasegawa1,2, Ashio Yoshimura1, Makoto Hirose1, Daisuke Komukai1, Hironori Tayama1, Susumu Watanabe1, Fumihiko Koiwa1, Shin Yamazaki2 and Terukuni Ideura1

Division of Nephrology,1 Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama; Department of Epidemiology and Healthcare Research,2 Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan

Correspondence to: T. Hasegawa, Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa, 227-8501, Japan. t-hasegawa{at}showa-university-fujigaoka.gr.jp


   ABSTRACT
TOP
 ABSTRACT
PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURE
 REFERENCES
 

{diamondsuit} Background: The factors that predict baseline peritoneal permeability remain largely unknown. We noticed that patients that adhered to a strict low protein diet (LPD) during the predialysis period seldom showed high peritoneal permeability on the peritoneal equilibration test (PET) at the introduction of peritoneal dialysis (PD). Therefore, we investigated whether a strict LPD during the predialysis period affects peritoneal permeability.

{diamondsuit} Method: We retrospectively analyzed 37 patients that started PD in a single Japanese center. Patients were divided into group A and group B by the median amount of daily protein intake (PI) during the predialysis period using urine collected over 24 hours.

{diamondsuit} Results: There were no differences between groups A and B in age, gender, proportion of diabetic nephropathy, blood pressure, body mass index, or body surface area. There were also no differences between the groups in laboratory findings, including hematocrit, serum albumin, and serum creatinine. The PETs showed a significantly lower dialysate-to-plasma ratio of creatinine at 4 hours (Cr D/P) for group A than for group B (p = 0.02). Furthermore, a significant positive correlation between Cr D/P and PI was observed (r = 0.53, p < 0.01).

{diamondsuit} Conclusion: It is suggested that a strict LPD during the predialysis period may suppress peritoneal permeability at induction of PD.

KEY WORDS: Low protein diet; peritoneal permeability; peritoneal equilibration test.

Early studies have reported a poorer prognosis (1,2), a higher hospitalization rate (3), and a higher risk of malnutrition (4) for peritoneal dialysis (PD) patients showing higher peritoneal permeability in the peritoneal equilibration test (PET). The Canada–USA Peritoneal Dialysis Study (CANUSA) (5), a large-scale study on the prognosis of PD patients, also showed that mortality rates are higher and technical survival is shorter in PD patients showing higher peritoneal permeability, and indicated that a higher peritoneal permeability is one of the risk factors for poor prognosis in PD patients (6). However, more recent investigations have not ascertained this association between higher peritoneal permeability and poorer prognosis for PD patients, especially in the current era of automated PD (7,8) and with use of icodextrin (9). Subsequent meta-analyses (10) have also confirmed these discrepant findings. Although it is presently controversial whether baseline peritoneal transport characteristics predict subsequent PD patient outcome, it is important to identify the factors that could influence peritoneal permeability at the commencement of PD.

On the other hand, it has been shown that a low protein diet (LPD) during the predialysis period of chronic kidney disease (CKD) not only improves uremic symptoms and delays the introduction of dialysis, but also prevents progression of CKD (11).

We noticed that patients that had adhered to a strict LPD during the predialysis period of CKD seldom showed high peritoneal permeability in PETs at the time of induction of PD (Figure 1). The mean and median amounts of daily protein intake (PI) in these patients were extremely low: 0.51 g/kg/day and 0.46 g/kg/day respectively. Comparison with the data of Mujais and Vonesh (12) revealed that the percentage of patients showing high peritoneal permeability in PETs at the beginning of PD was significantly lower for these patients. Therefore, we investigated whether a strict LPD during the predialysis period of CKD could affect peritoneal permeability at the time of induction of PD.


Figure 1
View larger version (14K):
[in this window]
[in a new window]

  		Figure 1 — Comparison of peritoneal equilibration test (PET) status distribution (Showa University Fujigaoka Hospital vs Mujais & Vonesh). Patients in the present study showed a significantly lower ratio of high peritoneal permeability in PETs at the induction of peritoneal dialysis (PD) than that of Mujais and Vonesh by chi-square test (p < 0.01) (12). *These patients had adhered to a low protein diet (mean and median protein intakes were 0.51 g/kg/day and 0.46 g/kg/day respectively) during the predialysis period.

 


   PATIENTS AND METHODS
TOP
 ABSTRACT
 PATIENTS AND METHODS
RESULTS
 DISCUSSION
 DISCLOSURE
 REFERENCES
 
PATIENT SELECTION AND STUDY DESIGN
We retrospectively analyzed 37 patients selected from 45 consecutive patients that started PD in Showa University Fujigaoka Hospital from 1 April 1998 through 31 March 2003. These selected patients were all advised continuously on a LPD during the predialysis period of CKD (mean and median periods of hospital assessment were 2.87 years and 1.32 years respectively). Their PI was determined using Maroni's formula for urea nitrogen appearance in urine collected over 24 hours (13). Their PI data were measured persistently during the predialysis period and the mean and median amounts of PI were calculated from more than three measured values during 1 year before the start of PD. PET data were analyzed as an indicator of peritoneal permeability. Following Twardowski's method (14), PET was performed within 1 month after PD catheterization and the ratios of dialysate-to-plasma creatinine (Cr D/P) at 4 hours and the ratios of dialysate glucose at 4 hours to the initial dialysate glucose (Glu D/D0) were calculated. The PET category was assigned on the basis of the results of Cr D/P. The 8 of 45 patients without PI data during the predialysis period, the main exposure to be tested in this investigation, were excluded from the analysis.

The 37 remaining patients were divided into group A and group B by median PI (0.46 g/kg/day): group A patients were below the median and group B patients were above the median. We then compared patient characteristics, laboratory findings, and PET data between the two groups. Correlations between PI and Cr D/P, as well as Glu D/D0, were also investigated.

STATISTICAL ANALYSIS
All data are expressed as mean ± standard deviation (SD). Comparisons between the two groups were made using the appropriate t-test after analysis of variance by F test. Ratios were compared between the two groups using the chi-square test. Linear regression analysis was performed for correlation between two variables. Statistical analysis was performed using Stata/SE 9.2 (Stata Corp., College Station, TX, USA). A p value less than 0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 PATIENTS AND METHODS
 RESULTS
DISCUSSION
 DISCLOSURE
 REFERENCES
 
CHARACTERISTICS AND LABORATORY FINDINGS OF THE PATIENTS
Table 1 shows the characteristics of the analyzed patients at the time of induction of PD. Mean age was 46.8 ± 15.0 years; 62.2% were males. Diabetic nephropathy was the cause of end-stage renal disease in 3 of the 37 patients.


View this table:
[in this window]
[in a new window]

  		TABLE 1 Patient Characteristics and Laboratory Findings at Induction of Peritoneal Dialysis

 

There were no significant differences between groups A and B with respect to age, gender, proportion of diabetic nephropathy, systolic/diastolic blood pressure, body mass index, or body surface area. The PI was 0.37 ± 0.05 g/kg/day for group A and 0.64 ± 0.13 g/kg/day for group B; the difference was significant (p < 0.01).

Laboratory findings are also shown in Table 1. Serum creatinine (Cr) was 14.4 ± 3.9 mg/dL for group A and 12.6 ± 4.3 mg/dL for group B; the difference was not significant. Neither serum albumin nor hematocrit differed significantly between groups A and B: 3.8 ± 0.4 vs 4.0 ± 0.5 g/dL and 23.2% ± 3.9% vs 24.9% ± 3.6% respectively.

RESULT OF PET
The comparison of the two groups with respect to PET data is shown in Figure 2. For group A, Cr D/P was 0.52 ± 0.08 and for group B it was 0.62 ± 0.14; it was significantly lower in group A than in group B (p = 0.02). For group A, Glu D/D0 was 0.51 ± 0.17 and for group B it was 0.43 ± 0.12: Glu D/D0 tended to be higher in group A than in group B (p = 0.16).


Figure 2
View larger version (16K):
[in this window]
[in a new window]

  		Figure 2 — Comparison of peritoneal equilibration test (PET) results (group A vs group B). PET revealed significantly lower dialysate-to-plasma ratio of creatinine at 4 hours by nonpaired t-test in group A than in group B (p = 0.02). Group A was comprised of patients below the median daily protein intake of 0.46 g/kg/day and group B patients were above.

 
Comparison of the PET status distribution between the two groups based on Cr D/P is shown in Figure 3. In group A, high and high-average groups were not recognized; the ratio of PET status distribution was significantly different between group A and group B (p = 0.03).


Figure 3
View larger version (11K):
[in this window]
[in a new window]

  		Figure 3 — Comparison of peritoneal equilibration test (PET) status distribution (group A vs group B). Group A showed a significantly lower ratio of high peritoneal permeability in their PETs based on dialysate-to-plasma ratio of creatinine at the induction of peritoneal dialysis than that of group B by chisquare test (p = 0.03). Group A was comprised of patients below the median daily protein intake of 0.46 g/kg/day and group B patients were above.

 

CORRELATION BETWEEN PI AND RESULTS OF THE PET
Correlation between PI and Cr D/P is shown in Figure 4. In linear regression analysis, the correlation coefficient r was 0.53 between PI and Cr D/P and they showed a significant positive correlation (p < 0.01). Correlation between PI and Glu D/D0 is shown in Figure 5. In linear regression analysis, r was –0.35 between PI and Glu D/D0. Albeit weak, there was also a significant negative correlation between these variables (p = 0.04).


Figure 4
View larger version (7K):
[in this window]
[in a new window]

  		Figure 4 — Correlation between daily protein intake (PI) and dialysate-to-plasma ratio of creatinine (Cr D/P). A significant positive correlation between PI and Cr D/P was observed (p < 0.01).

 

Figure 5
View larger version (7K):
[in this window]
[in a new window]

  		Figure 5 — Correlation between daily protein intake (PI) and glucose D/D0. A significant negative correlation between PI and Glu D/D0 was observed (p = 0.04).

 


   DISCUSSION
TOP
 ABSTRACT
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
DISCLOSURE
 REFERENCES
 
More than a quarter of a century has passed since Moncrief and Popovich et al. (15) first reported the clinical application of PD in the current style. Since then, innovations and improvements in PD catheters, peritoneal dialysate, and dialysis equipment have been made every year and clinical outcome has improved. Now PD plays an important role in renal replacement therapy for end-stage renal disease patients.

The CANUSA study (5) was a large-scale study of the prognosis of PD patients. In that study it was recognized that the higher the peritoneal permeability, the poorer the prognosis. According to the 2-year survival rate with respect to PET status, prognosis was better in the order low > low average > high average > high. Technical survival was also significantly shorter for the patients that showed high peritoneal permeability. These results indicate that high peritoneal permeability is a risk factor for poor prognosis. Since that study, reports concerning poor prognosis for patients with high peritoneal permeability have accumulated (1,2). There is also a report that showed high peritoneal permeability to be an independent risk factor for mortality (16); however, its mechanism has not yet been clarified (17). On the other hand, it has been reported that high peritoneal permeability is not disadvantageous clinically. Rather, it has been suggested that poor prognosis is correlated more significantly with concomitant complications such as chronic inflammation, malnutrition, and excess body fluid (18,19).

Meanwhile, it has been proposed that a LPD during the predialysis period of CKD improves uremic symptoms, delays the induction of dialysis, and suppresses progression of renal failure (11). We also enforced a strict LPD (0.39 g/kg/day), without supplementing amino acids and keto analogs, on very late-stage CKD patients (Cr ≥ 10 mg/dL) and reported that a strict LPD can not only prevent deterioration in renal function and delay induction of dialysis, but can also maintain a reasonable nutritional state (20). However, it is necessary to consider that there may be a risk of such a strict LPD leading to protein-energy malnutrition at the start of dialysis. This kind of malnutrition may be a consequence of uremia itself or related to comorbid conditions (21) and is a strong risk factor for PD patient survival (5,22).

We noticed that the patients that maintained a strict LPD during the predialysis period of CKD seldom showed high permeability in their PET at the time of induction of PD. Therefore, we carried out this study to examine the effects of a LPD during the predialysis period of CKD on peritoneal permeability at the induction of PD.

Consequently, we observed a significant positive correlation between PI and Cr D/P, and a significant negative correlation between PI and Glu D/D0. We also compared Cr D/P at the time of PD induction between two groups based on median amount of PI determined during the predialysis period (0.46 g/kg/day). Creatinine D/P at baseline was significantly lower in the group with less than the median amount of PI during the predialysis period. However, there were no differences between the groups in patient characteristics or laboratory findings. These results suggest that a strict LPD may suppress peritoneal permeability at the time of PD induction. An increase in blood flow in the peritoneal microcirculation and contributions of cytokines such as transforming growth factor-beta have been suggested as possible causes of increased peritoneal permeability (23). Future clinical and experimental studies are expected to further clarify these mechanisms.

It is necessary to consider selection bias in a single-center study such as the current investigation. Indeed, the proportion of diabetic nephropathy was very low in this study and adherence to a strict LPD generally presented some difficulty. Therefore, we have to recognize that our results may suffer from selection bias to some extent. We also have to consider that daily PI in this study was estimated by 24-hour urine urea excretion rather than by food records. Accordingly, if the patient was in an anabolic or a catabolic state, PI would be underestimated or overestimated respectively. We should also note that this investigation was observational and not a randomized controlled trial. It is the nature of an observational study that the association being recognized may suffer from confounding factors not measured. In this study, our findings may have been confounded by adherence/compliance issues in medication or diet therapy, which could have had an impact on other areas of the patient's medical care. Additional limitations of this study are its retrospective design and small sample size. However, our data provided some preliminary results on a possible factor that may suppress baseline peritoneal permeability and could improve outcomes in PD patients.

In conclusion, it is suggested that continuation of an adequate low protein diet during the predialysis period of CKD, based on strict protein restriction, may suppress peritoneal permeability at the time of PD induction.


   DISCLOSURE
TOP
 ABSTRACT
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURE
REFERENCES
 
This study was supported in part by grants for PD research from Baxter Japan Healthcare Corporation. There were no restrictions on publication nor conflicts of interest.

Received 17 January 2008; accepted 2 September 2008.


   REFERENCES
TOP
 ABSTRACT
 PATIENTS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURE
 REFERENCES
 

  1. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, et al. Peritoneal transport characteristics, comorbid diseases, and survival in CAPD patients. Perit Dial Int 2000;20 : 541-7.[Abstract/Free Full Text]
  2. Agarwal DK, Sharma AP, Gupta A, Sharma RK, Pandey CM, Kumar R, et al. Peritoneal equilibration test in Indian patients on continuous ambulatory peritoneal dialysis: does it affect patient outcome? Adv Perit Dial 2000; 16:148 -51.[Medline]
  3. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 1999; 33:927 -33.[Medline]
  4. Kang DH, Yoon KI, Choi KB, Lee R, Lee HY, Han DS, et al. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients. Nephrol Dial Transplant 1999; 14:1715 -22.[Abstract/Free Full Text]
  5. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996;7 : 198-207.[Abstract]
  6. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285 -92.[Abstract]
  7. Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY. Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoneal transport status. Perit Dial Int2001; 21(Suppl 3):S80 -5.[Abstract/Free Full Text]
  8. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948 -57.[Abstract/Free Full Text]
  9. Yang X, Fang W, Bargman JM, Oreopoulos DG. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int 2008; 28:82 -92.[Abstract/Free Full Text]
  10. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol2006; 17:2591 -8.[Abstract/Free Full Text]
  11. Aparicio M, Chauveau P, Combe C. Low protein diets and outcome of renal patients. J Nephrol 2001;14 : 433-9.[Medline]
  12. Mujais S, Vonesh E. Profiling of peritoneal ultrafiltration. Kidney Int Suppl 2002;81 : S17-22.[Medline]
  13. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27:58 -65.[Medline]
  14. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989;7 : 95-108.[Medline]
  15. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88:449 -56.[Abstract/Free Full Text]
  16. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998;13 : 962-8.[Abstract/Free Full Text]
  17. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999;19 : 17-22.[Abstract/Free Full Text]
  18. Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics. Adv Perit Dial 2000; 16:2 -6.[Medline]
  19. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN. Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int 2000; 20:14 -18.[Abstract/Free Full Text]
  20. Ideura T, Shimazui M, Higuchi K, Morita H, Yoshimura A. Effect of nonsupplemented low-protein diet on very late stage CRF. Am J Kidney Dis 2003; 41(3 Suppl 1): S31-4.[Medline]
  21. Bergstrom J. Why are dialysis patients malnourished? Am J Kidney Dis 1995; 26:229 -41.[Medline]
  22. Chung SH, Lindholm B, Lee HB. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int 2000;20 : 19-26.[Abstract/Free Full Text]
  23. Zemel D, Krediet RT. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Blood Purif 1996;14 : 198-216.[Medline]



This article has been cited by other articles:


Home page
 pdiHome page
T. Hasegawa, F. Koiwa, S. Yamazaki, and A. Yoshimura
In Reply to "Predialytic Period and Baseline Peritoneal Membrane Status: Any Connection?"
Perit. Dial. Int., July 1, 2010; 30(4): 478 - 480.
[Full Text] [PDF]

Home page
 pdiHome page
O. Balafa, C. A. Vlahu, A. M. Coester, D. G. Struijk, and R. T. Krediet
Predialytic Period and Baseline Peritoneal Membrane Status: Any Connection?
Perit. Dial. Int., May 1, 2010; 30(3): 380 - 381.
[Full Text] [PDF]

Home page
 pdiHome page
J. Perl and J. M. Bargman
PREDIALYSIS INTERVENTIONS FOR POSTDIALYSIS OUTCOMES
Perit. Dial. Int., May 1, 2009; 29(3): 270 - 273.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasegawa, T.
Right arrow Articles by Ideura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasegawa, T.
Right arrow Articles by Ideura, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS